AxoGen (AXGN) SEC Filings: History & Chart

AxoGen, Inc.(AXGN)

Medical - Devices · Alachua, FL

$37.22-0.17 (-0.45%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About AxoGen, Inc.

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM forms the basis of the AxoGuard Nerve Protector, which is utilized to encase and safeguard damaged peripheral nerves, supporting their reconstruction and preventing unwanted adhesions from surrounding soft tissues. Another ECM product, the AxoGuard Nerve Cap, isolates the nerve end from its environment to help mitigate the formation of painful neuromas. Furthermore, AxoGen provides the Avive Soft Tissue Membrane, a processed human umbilical cord membrane that functions as an absorbable covering for soft tissues, used to separate tissues within the surgical area. An additional tool available is the AxoTouch two-point discriminator, used for evaluating the density of nerve innervation on the skin's surface. These products are supplied to hospitals, surgery centers, and military medical facilities, catering to plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen's market reach extends across the United States, Canada, Germany, the United Kingdom, other European nations, South Korea, and internationally. The company's main operations are situated in Alachua, Florida.

Alachua, FL

622 employees

www.axogeninc.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Michael D. Dale

View full financials

Form	Filing Date	Accepted	Document
SC 13G	Oct 2, 2026	Oct 2, 2026	View filing
8-K	Oct 1, 2026	Oct 1, 2026	View filing
424B5	Sep 10, 2026	Sep 10, 2026	View filing
8-K/A	Sep 10, 2026	Sep 10, 2026	View filing
8-K	Sep 10, 2026	Sep 10, 2026	View filing
4	Sep 4, 2026	Sep 4, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
4	Aug 12, 2026	Aug 12, 2026	View filing
4	Aug 12, 2026	Aug 12, 2026	View filing
4	Aug 11, 2026	Aug 11, 2026	View filing
SC 13G/A	Jul 31, 2026	Jul 31, 2026	View filing
10-Q	Jul 29, 2026	Jul 29, 2026	View filing
8-K	Jul 29, 2026	Jul 29, 2026	View filing
4	Jun 26, 2026	Jun 26, 2026	View filing
4	Jun 26, 2026	Jun 26, 2026	View filing
4	Jun 26, 2026	Jun 26, 2026	View filing
4	Jun 26, 2026	Jun 26, 2026	View filing
4	Jun 26, 2026	Jun 26, 2026	View filing
4	Jun 26, 2026	Jun 26, 2026	View filing
4	Jun 26, 2026	Jun 26, 2026	View filing
8-K	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
4	May 12, 2026	May 12, 2026	View filing
4	May 8, 2026	May 8, 2026	View filing

SEC Filings

Recent Filings